Business Description
NovelStem International Corp
NAICS : 621511
SIC : 8071
ISIN : US67001V1098
Total Employee Number:
15Description
NovelStem International Corp is a holding company. Through its subsidiaries, the company is engaged in the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company also has an interest in a book publishing franchise.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -19.28 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | 0.71 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.88 | |||||
9-Day RSI | 49.35 | |||||
14-Day RSI | 48.59 | |||||
3-1 Month Momentum % | 4.84 | |||||
6-1 Month Momentum % | -29.35 | |||||
12-1 Month Momentum % | -38.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 4254.21 | |||||
ROIC % | -5.82 | |||||
3-Year ROIIC % | -152.16 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.19 | |||||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 0.25 | |||||
EV-to-EBIT | 0.88 | |||||
EV-to-EBITDA | 0.88 | |||||
EV-to-FCF | -9.15 | |||||
Earnings Yield (Greenblatt) % | 113.64 | |||||
FCF Yield % | -46.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NSTM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NovelStem International Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.06 | ||
| Beta | 5.4646 | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.54 | ||
| Volatility % | 151.49 | ||
| 14-Day RSI | 48.59 | ||
| 14-Day ATR ($) | 0.000353 | ||
| 20-Day SMA ($) | 0.011125 | ||
| 12-1 Month Momentum % | -38.1 | ||
| 52-Week Range ($) | 0.009 - 0.0357 | ||
| Shares Outstanding (Mil) | 49.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NovelStem International Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NovelStem International Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NovelStem International Corp Frequently Asked Questions
What is NovelStem International Corp(NSTM)'s stock price today?
The current price of NSTM is $0.01. The 52 week high of NSTM is $0.04 and 52 week low is $0.01.
When is next earnings date of NovelStem International Corp(NSTM)?
The next earnings date of NovelStem International Corp(NSTM) is .
Does NovelStem International Corp(NSTM) pay dividends? If so, how much?
NovelStem International Corp(NSTM) does not pay dividend.
Guru Commentaries on OTCPK:NSTM
No articles.
Articles on NovelStem International Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers